Month: June 2024

In May the EfTEN United Property Fund distributed almost 260 thousand euros to unit owners. As a result, the net asset value (NAV) of the fund unit fell by 0.9% to EUR 10.61 in May. Excluding the cash distribution, EfTEN United Property Fund NAV would have increased by 0.1%. If the fund’s investment in the EfTEN Real Estate Fund AS shares is reflected on the basis of its net value, the NAV of the EfTEN United Property Fund unit would be 10.70 euros. In June, the fund made the first investment of 24 thousand euros in EfTEN Capital AS’s new fund EfTEN Special Opportunities Fund aimed at institutional investors. This fund invests in various real estate projects that require additional financing to complete. The first investment, with a term of 50 months, co-financed the purchase of an office building in Vilnius. In total, EfTEN...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW CALGARY, Alberta, June 27, 2024 (GLOBE NEWSWIRE) — High Arctic Energy Services Inc. (TSX: HWO) (“High Arctic” or the “Corporation”) is pleased to announce that the Court of King’s Bench of Alberta has granted the final order in connection with the previously announced plan of arrangement (the “Arrangement”) between the Corporation and High Arctic Overseas Holdings Corp. (“SpinCo”) providing for the spin-out by the Corporation of its Papua New Guinea focused energy ‎services business to SpinCo. As previously announced, the Arrangement was approved by the Corporation’s shareholders at the annual general...

NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) — Chijet Motor Company, Inc. (NASDAQ: CJET) (the “Company” or “Chijet”), a high-tech enterprise engaged in the development, manufacture, sales, and service of traditional fuel vehicles and new energy vehicles (“NEV”), is pleased to announce that the Company’s annual shareholder meeting was held on June 28, 2024. At the meeting, the Company’s shareholders approved: (1) a reverse stock split (a “share consolidation” under Cayman Islands law) pursuant to which every 30 issued and unissued ordinary shares of the Company, par value US$0.0001 per share, is now consolidated into 1 ordinary share of the Company, par value US$ 0.003 per share; (2) an increase in the Company’s authorized share capital from US$50,000.00 divided into 16,666,667 authorized ordinary shares, par value of US$ 0.003 per...

SOUTH SAN FRANCISCO, Calif., June 27, 2024 (GLOBE NEWSWIRE) — Alumis Inc. (“Alumis” or the “Company”) (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing oral therapies using a precision approach to optimize clinical outcomes and significantly improve the lives of patients with immune-mediated diseases, today announced the pricing of its initial public offering of 13,125,000 shares of common stock at an initial public offering price of $16.00 per share. All shares of common stock are being offered by Alumis. In addition, Alumis has granted the underwriters a 30-day over-allotment option to purchase up to an additional 1,968,750 shares of common stock at the initial public offering price, less underwriting discounts and commissions. The shares are expected to begin trading on Nasdaq on June 28, 2024 under the symbol...

TORONTO, June 27, 2024 (GLOBE NEWSWIRE) — NowVertical Group Inc. (TSXV: NOW) (OTCQB: NOWVF) (“NOW” or the “Company”) announces the granting of 1,775,000 stock options (“Options”) and 1,775,000 restricted share units (“RSUs”) to certain members of the board of directors of the Company and members of the Company’s management team pursuant to the Company’s omnibus incentive compensation plan (the “Plan”). Each Option will entitle the holder thereof to acquire one (1) Class A subordinate voting share of the Company (the “Shares”) at an exercise price of $0.20 per Share, subject to vesting. The Options will vest in equal installments on the first, second and third anniversaries of the date of grant. The Options expire after five (5) years, unless forfeited earlier through departure of such participant. The RSUs will be issued pursuant...

CALGARY, Alberta, June 27, 2024 (GLOBE NEWSWIRE) — CEMATRIX Corporation (TSXV: CVX) (OTCQB: CTXXF) (“CEMATRIX” or the “Company“) a North American leading manufacturer and supplier of technologically advanced cellular concrete products today announced that it has secured an increase to its credit facility with the Canadian Imperial Bank of Commerce (“CIBC”) to support its ongoing growth and short-term annual working capital requirements during peak periods. The increased credit facility now has a maximum borrowing limit of $8 million, which represents a significant increase from the previous limit of $3 million. The other terms of the credit facility remain materially unchanged. The credit facility remains undrawn as of today’s date. “CEMATRIX is very pleased to announce this increase to our credit facility...

HOUSTON, TX, June 27, 2024 (GLOBE NEWSWIRE) — Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) today announced the pricing of a public offering of 3,000,000 shares of common stock at public offering price of $1.75. Gross proceeds, before deducting placement agent fees and other offering expenses, are expected to be approximately $5,250,000. Maxim Group LLC is acting as the sole placement agent for the offering. The offering is expected to close on July 1, 2024, subject to customary closing conditions. The securities described above were offered pursuant to a registration statement on Form S-1, as amended (File No. 333-279684) (the “Registration Statement”), which was declared effective by the Securities and Exchange Commission (the “SEC”) on June 27, 2024. The offering was made only by means...

China is the Third Country to Launch LEQEMBI Following the United States and Japan TOKYO and CAMBRIDGE, Mass., June 27, 2024 (GLOBE NEWSWIRE) — Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that the humanized anti-soluble aggregated amyloid-beta (Aβ) monoclonal antibody “LEQEMBI®” (brand name in China: “乐意保®”, generic name: lecanemab) has been launched in China. LEQEMBI received approval in January 2024 as a treatment of mild cognitive impairment (MCI) due to Alzheimer’s disease (AD) and mild AD dementia. China is the third country to launch LEQEMBI following the United States and Japan. LEQEMBI selectively binds to soluble Aβ aggregates (protofibrils*), as well as insoluble...